General Equity Doctors Diagnostic Imaging L P - TX Dallas, Dallas 75231

General Equity Doctors Diagnostic Imaging L P entered the industry of In Vitro Diagnostics in 2001 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 325413, which describes it as a In Vitro Diagnostics. For further clarification, the SIC classifies this business under the code 2835 and described it as a In Vitro Diagnostics. The business provides service to the B2B market.

To acquire more information, please contact Larry Nelson by calling (972) 759-5140 during business hours. You can also write to the business’ Single Location at 7515 Greenville Avenue # 200, Dallas, Texas TX 75231. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: General Equity Doctors Diagnostic Imaging L P
Representative: Larry Nelson
Place of Business: 7515 Greenville Avenue # 200, Dallas, TX 75231
Contact Number: (972) 759-5140
Type of Service: In Vitro Diagnostics
SIC Number: 2835
NAICS Number: 325413
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2001
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

General Equity Doctors Diagnostic Imaging L P is a company operating from Dallas, Texas providing professional In Vitro Diagnostics and relevant B2B variables. It was founded in 2001 and registered with the SIC code 2835 as In Vitro Diagnostics, and with the NAICS code 325413 as In Vitro Diagnostics.

With a current employee count of 1 to 4, General Equity Doctors Diagnostic Imaging L P has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Larry Nelson at (972) 759-5140 for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 7515 Greenville Avenue # 200 in Dallas, Texas 75231 and can be engaged online through the company website at , the company Twitter , and Facebook page .